HighTower Advisors’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-27,591
Closed -$145K 3954
2024
Q3
$145K Sell
27,591
-750
-3% -$4.32K ﹤0.01% 3227
2024
Q2
$194K Sell
28,341
-6,671
-19% -$61K ﹤0.01% 3043
2024
Q1
$360K Sell
35,012
-9,400
-21% -$69.5K ﹤0.01% 2541
2023
Q4
$368K Sell
44,412
-69,079
-61% -$497K ﹤0.01% 2559
2023
Q3
$711K Sell
113,491
-4,392
-4% -$19K ﹤0.01% 1982
2023
Q2
$513K Buy
117,883
+750
+0.6% +$1.67K ﹤0.01% 2182
2023
Q1
$200K Buy
117,133
+9,800
+9% +$17.3K ﹤0.01% 2759
2022
Q4
$209K Buy
107,333
+1,182
+1% +$2.65K ﹤0.01% 2742
2022
Q3
$209K Sell
106,151
-8,492
-7% -$20.2K ﹤0.01% 2579
2022
Q2
$233K Buy
114,643
+1,295
+1% +$3.22K ﹤0.01% 2527
2022
Q1
$403K Buy
113,348
+4,685
+4% +$16.6K ﹤0.01% 2328
2021
Q4
$422K Sell
108,663
-437
-0.4% -$2.06K ﹤0.01% 2261
2021
Q3
$677K Buy
109,100
+5,805
+6% +$49.5K ﹤0.01% 1877
2021
Q2
$1.22M Buy
103,295
+4,388
+4% +$50.5K ﹤0.01% 1518
2021
Q1
$1.56M Buy
98,907
+74,101
+299% +$1.33M ﹤0.01% 1274
2020
Q4
$163K Buy
+24,806
New +$182K ﹤0.01% 2254

Other funds holding LFMD

HighTower Advisors's LFMD Position: Q4 2024 in Review

HighTower Advisors sold out of LifeMD (LFMD) in Q4 2024, closing a stake of 27,591 shares — an estimated $145K sold.

HighTower Advisors first reported a position in LFMD in Q4 2020 and held it in 16 quarters. The position peaked at $1.56M in Q1 2021. 106 funds tracked by Wall St. Rank hold LFMD as of Q4 2024.

  • HighTower Advisors reported no remaining LifeMD position as of Q4 2024 after selling out during the quarter.
  • HighTower Advisors sold 27,591 LifeMD shares in Q4 2024, an estimated $145K.
  • HighTower Advisors first reported a position in LifeMD in Q4 2020 and held it in 16 quarters.
  • HighTower Advisors's LifeMD position peaked at $1.56M in Q1 2021.
  • 106 funds tracked by Wall St. Rank held LifeMD as of Q4 2024.

Based on HighTower Advisors's 13F filing for Q4 2024, filed 7 Feb 2025.